comparemela.com
Home
Live Updates
995861 : comparemela.com
995861
Among patients with atrial high-rate episodes detected by implantable devices, anticoagulation with edoxaban did not show a benefit but did increase bleeding risk in the NOAH-AFNET 6 trial.
Related Keywords
Canada ,
United Kingdom ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Hamburg ,
Germany ,
Indiana ,
United States ,
German ,
Stuart Connolly ,
Paulus Kirchhof ,
Barbara Casadei ,
Daiichi Sankyo Europe ,
Mcmaster University ,
Cardiovascular Research ,
American College Of Cardiology Ed Fry ,
Implications For Wearable Technology ,
University Heart ,
Vascular Center Hamburg ,
Vincent Heart Center ,
University Of Hamburg ,
German Center ,
European Society Of Cardiology ,
European Society ,
New England Journal ,
Medscape Cardiology ,
John Radcliffe Hospital ,
American College ,
Cardiology Ed Fry ,
Ascension Indiana ,
Daiichi Sankyo ,
Presented August ,
Atrial Fibrillation ,
F Atrial Fibrillation ,
Anticoagulation Therapy ,
Anticoagulant ,
Anticoagulation ,
Thromboembolism ,
Stroke ,
Erebrovascular Accident ,
Va Cerebrovascular Accident ,
Cardiometabolic Risk ,
Arrhythmia ,
Stroke Risk ,
Europe ,
European ,
Heart ,
Hemorrhage ,
Bleeding ,
Atrial Tachycardia ,
Embolism ,
Paroxysmal Supraventricular Tachycardia ,
Supraventricular Tachycardia ,
Vt Supraventricular Tachycar ,
comparemela.com © 2020. All Rights Reserved.